246 related articles for article (PubMed ID: 22705605)
1. Intracranial germ cell tumors: a single-institution experience.
Khafaga Y; El Weshi A; Nazmy M; Hassounah M; Alshail E; Moussa E; Allam A; Alkofide A; Jamshed A; ELhusseiny G; Ezzat I; Jenkin D
Ann Saudi Med; 2012; 32(4):359-65. PubMed ID: 22705605
[TBL] [Abstract][Full Text] [Related]
2. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
4. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes.
Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785
[TBL] [Abstract][Full Text] [Related]
5. Relapsing intracranial germ cell tumours warrant retreatment.
Callec L; Lardy-Cleaud A; Guerrini-Rousseau L; Alapetite C; Vignon L; Chastagner P; Frappaz D; Faure-Conter C
Eur J Cancer; 2020 Sep; 136():186-194. PubMed ID: 32711377
[TBL] [Abstract][Full Text] [Related]
6. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
[TBL] [Abstract][Full Text] [Related]
7. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
[TBL] [Abstract][Full Text] [Related]
8. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
[TBL] [Abstract][Full Text] [Related]
9. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Ariga H; Takai Y; Tominaga T
J Neurosurg Pediatr; 2009 Dec; 4(6):506-14. PubMed ID: 19951035
[TBL] [Abstract][Full Text] [Related]
10. Novel Diagnostic Methods and Posttreatment Clinical Phenotypes Among Intracranial Germ Cell Tumors.
Takami H; Perry A; Graffeo CS; Giannini C; Daniels DJ
Neurosurgery; 2020 Sep; 87(3):563-572. PubMed ID: 32348488
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the Management of Childhood Intracranial Germ Cell Tumors in Middle-Income Countries: A 20-Year Retrospective Review From a Single Tertiary Center in Malaysia.
Rajagopal R; Leong SH; Jawin V; Foo JC; Ahmad Bahuri NF; Mun KS; Azman RR; Loh J; Yap TY; Ariffin H; Moreira DC; Gottardo NG; Bouffet E; Ganesan D
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e913-e923. PubMed ID: 33633029
[TBL] [Abstract][Full Text] [Related]
12. Multimodality treatment for Central Nervous System Germ Cell Tumors: Disease spectrum and management strategies - A tertiary care center experience from India.
Kumar N; Madan R; Dracham CB; Khosla D; Das N; Dey T; Elangovan A; Tripathi M; Gupta K; Ahuja CK; Kapoor R
Clin Neurol Neurosurg; 2021 Mar; 202():106481. PubMed ID: 33508649
[TBL] [Abstract][Full Text] [Related]
13. The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
Sun XF; Zhang F; Zhen ZJ; Yang QY; Xia YF; Wu SX; Zhu J; Lu SY; Wang J; Sun FF; Cai RQ; Chen Y; Li PF
Chin J Cancer; 2014 Aug; 33(8):395-401. PubMed ID: 25011460
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
[TBL] [Abstract][Full Text] [Related]
15. Paediatric germ cell tumours of the central nervous system: Results and experience from a tertiary-referral paediatric institution in Australia.
Carlos Chung KH; Owler BK; Dexter M; Chaseling R
J Clin Neurosci; 2013 Apr; 20(4):514-9. PubMed ID: 23317752
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
17. Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors.
De B; Cahlon O; Dunkel IJ; De Braganca KC; Khakoo Y; Gilheeney SW; Souweidane MM; Wolden SL
J Neurooncol; 2017 Sep; 134(2):349-356. PubMed ID: 28660318
[TBL] [Abstract][Full Text] [Related]
18. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
Lai IC; Wong TT; Shiau CY; Hu YW; Ho DM; Chang KP; Guo WY; Chang FC; Liang ML; Lee YY; Chen HH; Yen SH; Chen YW
Childs Nerv Syst; 2015 May; 31(5):683-91. PubMed ID: 25749900
[TBL] [Abstract][Full Text] [Related]
19. Brain and Spinal Tumors Originating from the Germ Line Cells.
Wong TT; Tsai ML; Chang H; Hsieh KL; Ho DM; Lin SC; Yen HJ; Chen YW; Lee HL; Yang TF
Adv Exp Med Biol; 2023; 1405():421-455. PubMed ID: 37452948
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of residual tissues after adjuvant therapy in germ cell tumors.
Nakamura H; Takeshima H; Makino K; Kuratsu J
Pediatr Neurosurg; 2007; 43(2):82-91. PubMed ID: 17337917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]